Matching articles for "botulism antitoxin"
Issue 1443 · May 26, 2014 Free
In Brief: Heptavalent Botulism Antitoxin

The FDA has approved the use of an equine heptavalent botulism antitoxin (BAT, Cangene Corporation). The new antitoxin includes antibodies against all 7 botulinum neurotoxin types (A-G). A human-derived…

Med Lett Drugs Ther. 2014 May 26; 56(1443):44
The FDA has approved the use of an equine heptavalent botulism antitoxin (BAT, Cangene Corporation). The new antitoxin includes antibodies against all 7 botulinum neurotoxin types (A-G). A human-derived antitoxin (BabyBIG) has been available for years for infant botulism. The heptavalent product is now the preferred antitoxin for adult botulism. It is a solution of immunoglobulin fragments obtained from equine plasma that has gone through several steps of purification and viral inactivation. (The use of immunoglobulin fragments reduces side effects compared to intact immunoglobulin.) BAT is available from the CDC through state and local health departments. Download complete U.S. English article